img

Global Human Low-Pass Whole Genome Sequencing Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Human Low-Pass Whole Genome Sequencing Market Insights, Forecast to 2034

Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
Market Analysis and InsightsGlobal Human Low-Pass Whole Genome Sequencing Market
Global Human Low-Pass Whole Genome Sequencing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Low-Pass Whole Genome Sequencing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Human Low-Pass Whole Genome Sequencing key companies include BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, Healgen Scientific, Agilent Technologies, Macrogen and Veritas Genetics, etc. BGI, Breda Genetics, Azenta Life Sciences are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Human Low-Pass Whole Genome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Human Low-Pass Whole Genome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Human Low-Pass Whole Genome Sequencing can be divided into Large Human Low-Through Whole Genome Sequencing (> 5 Mb) and Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb), etc. Large Human Low-Through Whole Genome Sequencing (> 5 Mb) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Human Low-Pass Whole Genome Sequencing is widely used in various fields, such as Medical, Scientific Research and Others,, etc. Medical provides greatest supports to the Human Low-Pass Whole Genome Sequencing industry development. In 2022, global % revenue of Human Low-Pass Whole Genome Sequencing went into Medical filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Human Low-Pass Whole Genome Sequencing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Human Low-Pass Whole Genome Sequencing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


BGI
Breda Genetics
Azenta Life Sciences
Thermo Fisher Scientific
Psomagen
Healgen Scientific
Agilent Technologies
Macrogen
Veritas Genetics
Centogene
Nebula Genomics
CD Genomics
Segment by Type
Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)

Segment by Application


Medical
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Human Low-Pass Whole Genome Sequencing introduction, etc. Human Low-Pass Whole Genome Sequencing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Human Low-Pass Whole Genome Sequencing
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
1.2.3 Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
1.3 Market by Application
1.3.1 Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Low-Pass Whole Genome Sequencing Market Perspective (2018-2033)
2.2 Global Human Low-Pass Whole Genome Sequencing Growth Trends by Region
2.2.1 Human Low-Pass Whole Genome Sequencing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Human Low-Pass Whole Genome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Region (2024-2033)
2.3 Human Low-Pass Whole Genome Sequencing Market Dynamics
2.3.1 Human Low-Pass Whole Genome Sequencing Industry Trends
2.3.2 Human Low-Pass Whole Genome Sequencing Market Drivers
2.3.3 Human Low-Pass Whole Genome Sequencing Market Challenges
2.3.4 Human Low-Pass Whole Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Human Low-Pass Whole Genome Sequencing by Players
3.1.1 Global Human Low-Pass Whole Genome Sequencing Revenue by Players (2018-2023)
3.1.2 Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Human Low-Pass Whole Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human Low-Pass Whole Genome Sequencing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Human Low-Pass Whole Genome Sequencing Market Concentration Ratio
3.4.1 Global Human Low-Pass Whole Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Low-Pass Whole Genome Sequencing Revenue in 2022
3.5 Global Key Players of Human Low-Pass Whole Genome Sequencing Head office and Area Served
3.6 Global Key Players of Human Low-Pass Whole Genome Sequencing, Product and Application
3.7 Global Key Players of Human Low-Pass Whole Genome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Low-Pass Whole Genome Sequencing Breakdown Data by Type
4.1 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Type (2024-2033)
5 Human Low-Pass Whole Genome Sequencing Breakdown Data by Application
5.1 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
6.2 North America Human Low-Pass Whole Genome Sequencing Market Size by Type
6.2.1 North America Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
6.2.2 North America Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
6.2.3 North America Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
6.3 North America Human Low-Pass Whole Genome Sequencing Market Size by Application
6.3.1 North America Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
6.3.2 North America Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
6.3.3 North America Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
6.4 North America Human Low-Pass Whole Genome Sequencing Market Size by Country
6.4.1 North America Human Low-Pass Whole Genome Sequencing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
6.4.3 North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
7.2 Europe Human Low-Pass Whole Genome Sequencing Market Size by Type
7.2.1 Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
7.2.2 Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
7.2.3 Europe Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
7.3 Europe Human Low-Pass Whole Genome Sequencing Market Size by Application
7.3.1 Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
7.3.2 Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
7.3.3 Europe Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
7.4 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country
7.4.1 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
7.4.3 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
8.2 China Human Low-Pass Whole Genome Sequencing Market Size by Type
8.2.1 China Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
8.2.2 China Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
8.2.3 China Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
8.3 China Human Low-Pass Whole Genome Sequencing Market Size by Application
8.3.1 China Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
8.3.2 China Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
8.3.3 China Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
9.2 Asia Human Low-Pass Whole Genome Sequencing Market Size by Type
9.2.1 Asia Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
9.2.2 Asia Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
9.2.3 Asia Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
9.3 Asia Human Low-Pass Whole Genome Sequencing Market Size by Application
9.3.1 Asia Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
9.3.2 Asia Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
9.3.3 Asia Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
9.4 Asia Human Low-Pass Whole Genome Sequencing Market Size by Region
9.4.1 Asia Human Low-Pass Whole Genome Sequencing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023)
9.4.3 Asia Human Low-Pass Whole Genome Sequencing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BGI
11.1.1 BGI Company Details
11.1.2 BGI Business Overview
11.1.3 BGI Human Low-Pass Whole Genome Sequencing Introduction
11.1.4 BGI Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.1.5 BGI Recent Developments
11.2 Breda Genetics
11.2.1 Breda Genetics Company Details
11.2.2 Breda Genetics Business Overview
11.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Introduction
11.2.4 Breda Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.2.5 Breda Genetics Recent Developments
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Details
11.3.2 Azenta Life Sciences Business Overview
11.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Introduction
11.3.4 Azenta Life Sciences Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.3.5 Azenta Life Sciences Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Psomagen
11.5.1 Psomagen Company Details
11.5.2 Psomagen Business Overview
11.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Introduction
11.5.4 Psomagen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.5.5 Psomagen Recent Developments
11.6 Healgen Scientific
11.6.1 Healgen Scientific Company Details
11.6.2 Healgen Scientific Business Overview
11.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Introduction
11.6.4 Healgen Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.6.5 Healgen Scientific Recent Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Introduction
11.7.4 Agilent Technologies Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.7.5 Agilent Technologies Recent Developments
11.8 Macrogen
11.8.1 Macrogen Company Details
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Introduction
11.8.4 Macrogen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.8.5 Macrogen Recent Developments
11.9 Veritas Genetics
11.9.1 Veritas Genetics Company Details
11.9.2 Veritas Genetics Business Overview
11.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Introduction
11.9.4 Veritas Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.9.5 Veritas Genetics Recent Developments
11.10 Centogene
11.10.1 Centogene Company Details
11.10.2 Centogene Business Overview
11.10.3 Centogene Human Low-Pass Whole Genome Sequencing Introduction
11.10.4 Centogene Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.10.5 Centogene Recent Developments
11.11 Nebula Genomics
11.11.1 Nebula Genomics Company Details
11.11.2 Nebula Genomics Business Overview
11.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Introduction
11.11.4 Nebula Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.11.5 Nebula Genomics Recent Developments
11.12 CD Genomics
11.12.1 CD Genomics Company Details
11.12.2 CD Genomics Business Overview
11.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Introduction
11.12.4 CD Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
11.12.5 CD Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Table 3. Key Players of Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
Table 4. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Human Low-Pass Whole Genome Sequencing Market Share by Region (2018-2023)
Table 8. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Human Low-Pass Whole Genome Sequencing Market Share by Region (2024-2033)
Table 10. Human Low-Pass Whole Genome Sequencing Market Trends
Table 11. Human Low-Pass Whole Genome Sequencing Market Drivers
Table 12. Human Low-Pass Whole Genome Sequencing Market Challenges
Table 13. Human Low-Pass Whole Genome Sequencing Market Restraints
Table 14. Global Human Low-Pass Whole Genome Sequencing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Human Low-Pass Whole Genome Sequencing Revenue Share by Players (2018-2023)
Table 16. Global Top Human Low-Pass Whole Genome Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Low-Pass Whole Genome Sequencing as of 2022)
Table 17. Global Human Low-Pass Whole Genome Sequencing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Human Low-Pass Whole Genome Sequencing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Human Low-Pass Whole Genome Sequencing, Headquarters and Area Served
Table 20. Global Key Players of Human Low-Pass Whole Genome Sequencing, Product and Application
Table 21. Global Key Players of Human Low-Pass Whole Genome Sequencing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2023)
Table 25. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2024-2033)
Table 27. Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Human Low-Pass Whole Genome Sequencing Revenue Share by Application (2018-2023)
Table 29. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Human Low-Pass Whole Genome Sequencing Revenue Share by Application (2024-2033)
Table 31. North America Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Human Low-Pass Whole Genome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Human Low-Pass Whole Genome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Human Low-Pass Whole Genome Sequencing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Human Low-Pass Whole Genome Sequencing Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 63. BGI Company Details
Table 64. BGI Business Overview
Table 65. BGI Human Low-Pass Whole Genome Sequencing Product
Table 66. BGI Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 67. BGI Recent Developments
Table 68. Breda Genetics Company Details
Table 69. Breda Genetics Business Overview
Table 70. Breda Genetics Human Low-Pass Whole Genome Sequencing Product
Table 71. Breda Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 72. Breda Genetics Recent Developments
Table 73. Azenta Life Sciences Company Details
Table 74. Azenta Life Sciences Business Overview
Table 75. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product
Table 76. Azenta Life Sciences Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 77. Azenta Life Sciences Recent Developments
Table 78. Thermo Fisher Scientific Company Details
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product
Table 81. Thermo Fisher Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Developments
Table 83. Psomagen Company Details
Table 84. Psomagen Business Overview
Table 85. Psomagen Human Low-Pass Whole Genome Sequencing Product
Table 86. Psomagen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 87. Psomagen Recent Developments
Table 88. Healgen Scientific Company Details
Table 89. Healgen Scientific Business Overview
Table 90. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product
Table 91. Healgen Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 92. Healgen Scientific Recent Developments
Table 93. Agilent Technologies Company Details
Table 94. Agilent Technologies Business Overview
Table 95. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product
Table 96. Agilent Technologies Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 97. Agilent Technologies Recent Developments
Table 98. Macrogen Company Details
Table 99. Macrogen Business Overview
Table 100. Macrogen Human Low-Pass Whole Genome Sequencing Product
Table 101. Macrogen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 102. Macrogen Recent Developments
Table 103. Veritas Genetics Company Details
Table 104. Veritas Genetics Business Overview
Table 105. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product
Table 106. Veritas Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 107. Veritas Genetics Recent Developments
Table 108. Centogene Company Details
Table 109. Centogene Business Overview
Table 110. Centogene Human Low-Pass Whole Genome Sequencing Product
Table 111. Centogene Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 112. Centogene Recent Developments
Table 113. Nebula Genomics Company Details
Table 114. Nebula Genomics Business Overview
Table 115. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product
Table 116. Nebula Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 117. Nebula Genomics Recent Developments
Table 118. CD Genomics Company Details
Table 119. CD Genomics Business Overview
Table 120. CD Genomics Human Low-Pass Whole Genome Sequencing Product
Table 121. CD Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 122. CD Genomics Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Human Low-Pass Whole Genome Sequencing Market Share by Type: 2022 VS 2033
Figure 3. Large Human Low-Through Whole Genome Sequencing (> 5 Mb) Features
Figure 4. Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb) Features
Figure 5. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Human Low-Pass Whole Genome Sequencing Market Share by Application: 2022 VS 2033
Figure 7. Medical Case Studies
Figure 8. Scientific Research Case Studies
Figure 9. Others Case Studies
Figure 10. Human Low-Pass Whole Genome Sequencing Report Years Considered
Figure 11. Global Human Low-Pass Whole Genome Sequencing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Human Low-Pass Whole Genome Sequencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Human Low-Pass Whole Genome Sequencing Market Share by Region: 2022 VS 2033
Figure 14. Global Human Low-Pass Whole Genome Sequencing Market Share by Players in 2022
Figure 15. Global Top Human Low-Pass Whole Genome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Low-Pass Whole Genome Sequencing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Human Low-Pass Whole Genome Sequencing Revenue in 2022
Figure 17. North America Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 19. North America Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 20. North America Human Low-Pass Whole Genome Sequencing Market Share by Country (2018-2033)
Figure 21. United States Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Human Low-Pass Whole Genome Sequencing Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 25. Europe Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 26. Europe Human Low-Pass Whole Genome Sequencing Market Share by Country (2018-2033)
Figure 27. Germany Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Human Low-Pass Whole Genome Sequencing Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 35. China Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 36. Asia Human Low-Pass Whole Genome Sequencing Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 38. Asia Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 39. Asia Human Low-Pass Whole Genome Sequencing Market Share by Region (2018-2033)
Figure 40. Japan Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Human Low-Pass Whole Genome Sequencing Market Share by Country (2018-2033)
Figure 50. Brazil Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Human Low-Pass Whole Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. BGI Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 57. Breda Genetics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 58. Azenta Life Sciences Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 60. Psomagen Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 61. Healgen Scientific Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 62. Agilent Technologies Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 63. Macrogen Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 64. Veritas Genetics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 65. Centogene Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 66. Nebula Genomics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 67. CD Genomics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries